Enhancement of salivary IgA response to a DNA vaccine against Streptococcus mutans wall-associated protein A in mice by plasmid-based adjuvants

Journal of Medical Microbiology

Volumn 56, Issue 5, 2007, Pages 675-680

  Hant, Thomas K ^a,b   My, Lien Dao ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; COMPLEMENTARY DNA; DNA VACCINE; IMMUNOGLOBULIN A; INTERLEUKIN 5; PROTEIN A;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GENE; CHOLERA TOXIN B GENE; CONTROLLED STUDY; EMBRYO; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNITY; IMMUNIZATION; INTERLEUKIN 5 GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STREPTOCOCCUS MUTANS; WALL ASSOCIATED PROTEIN A GENE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHOLERA TOXIN; FEMALE; GENETIC VECTORS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; INTERLEUKIN-5; MICE; MICE, INBRED BALB C; PLASMIDS; SALIVA; STREPTOCOCCAL VACCINES; STREPTOCOCCUS MUTANS; VACCINES, DNA;

EID: 34248141167     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47020-0     Document Type: Article

References (25)

1. Curzon, M. E. J. & Preston, A. J. (2004). Risk groups: nursing bottle caries/caries in elderly. Caries Res 38, 24-33.
2. Dao, M. L. (1985). An improved method of antigen detection on nitrocellulose: in situ staining of alkaline phosphatase conjugated antibody. J Immunol Methods 82, 225-231.
3. De Magistris, M. T., Pizza, M., Douce, G., Ghiara, P., Dougan, G. & Rappuoli, R. (1998). Adjuvant effect of non-toxic mutants of E. coli heat-labile enterotoxin following intranasal, oral and intravaginal immunization. Dev Biol Stand 92, 123-126.
4. Donnelly, J. J., Ulmer, J. B. & Liu, M. A. (1997). DNA vaccines. Life Sci 60, 163-172.
5. George-Chandy, A., Eriksson, K., Lebens, M., Nordstrom, I., Schon, E. & Holmgren, J. (2001). Cholera toxin B subunit as a carrier protein promotes antigen presentation and increases CD40 and C86 expression on antigen-presenting cells. Infect Immun 69, 5716-5725.
6. Han, T. K. & Dao, M. L. (2005). Differential immunogenicity of a DNA vaccine containing the Streptococcus mutans wall-associated protein A gene versus that containing a truncated derivative antigen A lacking in the hydrophobic carboxyterminal region. DNA Cell Biol 24, 574-581.
7. Han, T. K., Yoder, S., Cao, C., Ugen, K. E. & Dao, M. L. (2001). Expression of Streptococcus mutans wall-associated protein A gene in Chinese hamster ovary cells: prospect for a dental caries DNA vaccine. DNA Cell Biol 20, 595-601.
8. Jia, R., Guo, J. H., Fan, U. W., Bian, Z., Chen, Z., Fan, B., Yu, F. & Xu, Q. A. (2006). Immunogenicity of CTLA4 fusion anti-caries DNA vaccine in rabbits and monkeys. Vaccine 24, 5192-5200.
9. Klavinskis, L. S., Gao, L., Barnfield, C., Lehner, T. & Parker, S. (1997). Mucosal immunization with DNA-liposome complexes. Vaccine 15, 818-820.
10. Klavinskis, L. S., Barnfield, C., Gao, L. & Parker, S. (1999). Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. J Immunol 162, 254-262.
11. Letvin, N. L., Montefiori, D. C., Yasutomi, Y., Perry, H. C., Davies, M. E., Lekutis, C., Alroy, M., Freed, D. L., Lord, C. I. & other authors (1997). Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci USA 94, 9378-9383.
12. Lowe, D. B., Shearer, M. H. & Kennedy, R. C. (2006). DNA vaccines: successes and limitations in cancer and infectious disease. J Cell Biochem 98, 235-242.
13. Ochiya, T., Takahama, Y., Baba-Toriyama, H., Tsukamoto, M., Yasuda, Y., Kikuchi, H. & Terada, M. (1999). Evaluation of cationic liposome suitable for transfer into pregnant animals. Biochem Biophys Res Commun 258, 328-365.
14. Okada, E., Sasaki, S., Ishii, N., Aoki, I., Yasuda, T., Nichioka, K., Fukushima, J., Miyazaki, J.-I., Wahren, B. & Okuda, K. (1997). Intranasal immunization of a DNA vaccine with IL-12 and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J Immunol 159, 3638-3647.
15. Perrie, Y., Frederik, P. M. & Gregoriadis, G. (2001). Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine 19, 3301-3310.
16. Qian, H. & Dao, M. L. (1993). Inactivation of the Streptococcus mutans wall-associated protein A gene (wapA) results in a decrease in sucrose dependent adherence and aggregation. Infect Immun 61, 5021-5028.
17. Ramsay, A. J. & Kohonen-Corish, M. (1993). Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo. Eur J Immunol 23, 3141-3145.
18. Robinson, H. L., Montefiori, D. C., Johnson, R. P., Manson, K. H., Kalish, M. L., Lifson, J. D., Rizvi, T. A., Lu, S., Hu, S. L. & other authors (1999). Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat Med 5, 526-534.
19. Rugg-gunn, A. (2001). Preventing the preventable - the enigma of dental caries. Br Dent J 191, 478-488.
20. Shiver, J. W., Davies, M.-E., Perry, H. C., Freed, D. C. & Liu, M. A. (1996). Humoral and cellular immunities elicited by HIV-1 DNA vaccination. J Pharm Sci 85, 1317-1324.
21. Whiley, R. A., Russell, R. R. B., Hardie, J. M. & Beighton, D. (1988). Streptococcus downei sp. nov. for strains previously described as Streptococcus mutans serotype h. Int J Syst Bacteriol 38, 25-29.
22. Whittle, B. L., Smith, R. M., Matthaei, K. I., Young, I. G. & Verma, N. K. (1997). Enhancement of the specific mucosal IgA response in vivo by interleukin-5 expressed by an attenuated strain of Salmonella serotype Dublin. J Med Microbiol 46, 1029-1038.
23. Wu, H. Y. & Russell, M. W. (1993). Induction of mucosal immunity by intranasal application of a surface protein with the cholera toxin B subunit. Infect Immun 61, 314-322.
24. Yasuda, Y., Matano, K., Asai, T. & Tochikubo, K. (1998). Affinity purification of recombinant cholera toxin B subunit oligomer expressed in Bacillus brevis for potential human use as a mucosal adjuvant. FEMS Immunol Med Microbiol 20, 311-318.
25. Yoder, S. C., Cao, C., Ugen, K. E. & Dao, M. L. (2000). High-level expression of a truncated wall-associated protein A from the dental cariogenic Streptococcus mutans. DNA Cell Biol 19, 401-408.